ArticleCardiovascular diabetology2021

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect.

Enrique Z Fisman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.